Purchase Order VA77015P0906
- Not listed
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $11,840.66, is a firm fixed-price delivery order issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) worth up to $499,999,999. The IDC,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The $21,485.52 firm fixed-price delivery order contract has an ultimate completion date of September 13, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract has a ceiling value of $14,901.09 and is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the Defense Logistics Agency's (DLA) SPE2DB pharmaceutical prime vendor program. The award, valued at $76,729.25, is for the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military health...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for a Firm Fixed Price Purchase Order to refill the needs of the Department of Veterans Affairs Consolidated Mail Outpatient Pharmacy (CMOP). The award, valued at $124,110.00, does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $12,934.05. The contract was awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program, which provides pharmaceutical and medical supplies to the Department of Defense (DoD) and Department of Veterans Affairs (VA). DMS Pharmaceutical Group specializes in supplying a wide range of branded and generic prescription drugs,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the supply of various pharmaceutical products to the U.S. government, primarily the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $1,030.00, is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA)...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $9,284.40 under the SPE2DB program administered by the Defense Logistics Agency (DLA). The contract covers the provision of a diverse range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for a Prime Vendor Pharmaceutical program supporting the Department of Defense (DoD) and Department of Veterans Affairs (VA). The $30,695.04 firm fixed-price delivery order covers a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical supplies....
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare facilities. The contract, valued up to $1,892.90, is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the provision of open market pharmaceuticals to the Department of Veterans Affairs, Veterans Integrated Service Network 12. The award, valued at $109,464.00, is a firm fixed-price purchase order with an ultimate completion date of September 2, 2015. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract is not associated with a set-aside designation, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across multiple product categories and medical domains. Additionally, DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026, further positioning the company as a crucial supplier in the federal pharmaceutical supply chain.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
RX, 8 Line Items, 765-IL | VA77015Q0257 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Award Notice 1/1 | 8/5/15, 5:03 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Change Order | $1.4k | 8/24/15 | |
| Not listed | Not listed | $108.0k | 8/19/15 |